⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

PVLA

Palvella Therapeutics, Inc.

Healthcare · Biotechnology

125.10USD

-1.2900 (-1.02%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on PVLA.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 125.10
P/E—
Dvd Ind Yld0.0%
P/B8.31
P/S1,333.2
Curr EV/T12M EBITDA459.2
Mkt Cap (USD)1.8B
Curr EV (USD)1.6B
2)

Per Share Data

EPS T12M-4.88
DPS—
Bk Val Per Sh15.07
Rev/Sh0.09
Cash/Sh17.39
Curr Shares Out14.4M
FCF/Sh1.05
3)

Cash Flow Analysis

P/CF-49.4
Curr P/FCF120.1
CF/NI0.6
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-2700.7%
Eff Interest Rate0.8%
4)

Growth Potential

Dil EPS 1Y Gr-136.9%
Cap 1Y Gr-55.3%
BPS 1Y Gr-55.8%
R&D To Sales2622.5%
Retention Rate100.0%
Rev 1Y Gr65.3%
FCF 1Y Gr77.2%
Assets 1Y Gr-32.5%
5)

Profitability

EBITDA0.0B
EBIT-0.1B
Operating Margin-4270.8%
Pretax Margin-4563.3%
Net Margin-4563.3%
ROA-37.7%
ROE-46.6%
ROC-24.1%
Asset Turnover0.01
6)

Structure

Current Ratio21.18
Quick Ratio21.01
Debt/Assets8.9%
Debt/Com Eq10.4%
Net Debt/EBITDA-48.17
Tot Debt/Capital9.5%
Gross Margin0.0%
EBIT/Int Exp-319.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.